SHC - Director At Sotera Health Sells $237.42M Of Stock | Benzinga
WARBURG PINCUS CO, Director at Sotera Health (NASDAQ:SHC), reported an insider sell on March 6, according to a new SEC filing.
What Happened: CO's decision to sell 16,594,363 shares of Sotera Health was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday. The total value of the sale is $237,423,848.
The latest update on Thursday morning shows Sotera Health shares down by 0.0%, trading at $14.23.
Get to Know Sotera Health Better
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and advanced applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe, and other regions.
Sotera Health: A Financial Overview
Revenue Growth: Over the 3 months period, Sotera Health showcased positive performance, achieving a revenue growth rate ...